Sharekhan

Amanta Healthcare Ltd

Fri 22/05/2026,15:44:18 | NSE : AMANTA

₹ 130.093.85 (3.05%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 126.61

Previous Close

₹ 126.24

Volume

47650

Mkt Cap ( Rs. Cr)

₹505.13

High

₹ 131.99

Low

₹ 125.12

52 Week High

₹ 154.40

52 Week Low

₹ 92.00

Book Value Per Share

₹ 55.45

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Amanta Healthcare Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

130.09

20

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

20

Option Chain

Analyzes market sentiment, predicts Amanta Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2026, 5:45PM Amanta Healthcare Limited has informed the Exchange about Transcript
  • Amanta Healthcare - Copy of Newspaper Publication

    21 May 2026, 2:17PM Amanta Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    21 May 2026, 5:49PM Announcement under Regulation 30 (LODR) - Earnings Call Transcript
  • Amanta Healthcare Q4 net profit down 7.21% at Rs 5.53 cr

    19 May 2026, 7:30PM The company reported standalone net profit of Rs 5.53 crore for the quarter ended March 31, 2026 as compared to Rs 5.96 crore in the same period last
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    19 May 2026, 5:45PM Amanta Healthcare Limited has informed the Exchange about Link of Recording
  • Amanta Healthcare - General Updates

    19 May 2026, 3:42PM Amanta Healthcare Limited has informed the Exchange about General Updates
  • Amanta Healthcare - Change in Auditors

    19 May 2026, 3:40PM Amanta Healthcare Limited has informed the Exchange regarding Change in Auditors of the company.
  • Amanta Healthcare - General Updates

    19 May 2026, 3:38PM Amanta Healthcare Limited has informed the Exchange about Amendment to the code
  • Amanta Healthcare - Outcome of Board Meeting

    19 May 2026, 3:37PM Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Amanta Healthcare - Press Release

    19 May 2026, 3:33PM Amanta Healthcare Limited has informed the Exchange regarding a press release dated May 19, 2026, titled ""Amanta Healthcare Limited announcesQ4 & FY2
  • Amanta Healthcare - Investor Presentation

    19 May 2026, 3:32PM Amanta Healthcare Limited has informed the Exchange about Investor Presentation
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    19 May 2026, 5:41PM Intimation of Audio Recording for earnings Conference Call held on May 19, 2026
  • Amanta Healthcare - Revision In Remuneration Of Managing Director - Recommended By Board Of Directors

    19 May 2026, 3:48PM Revision in Remuneration of Managing Director - subject to shareholders approval
  • Amanta Healthcare - Change In Auditors

    19 May 2026, 3:46PM Recommendation by Board for Appointment/Re-appointment of auditors
  • Amanta Healthcare - Press Release

    19 May 2026, 3:30PM Intimation of press release
  • Amanta Healthcare - Investor Presentation

    19 May 2026, 3:27PM Investor presentation
  • Amanta Healthcare - Amendment To The Code

    19 May 2026, 3:25PM Amendment to the code
  • Amanta Healthcare - Financial Results For FY 2025-26

    19 May 2026, 3:24PM Intimation of Financial Results for FY 2025-26
  • Amanta Healthcare - Board Meeting Outcome for Audited Financial Results For FY 2025-26

    19 May 2026, 3:19PM Intimation of Audited Financial Results for FY 2025-26
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2026, 11:01AM Amanta Healthcare Limited has informed the Exchange about Schedule of meet
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 May 2026, 10:52AM Intimation of Schedule of the Earnings Conference Call for Q4 and Year ended March 31, 2026
  • Amanta Healthcare - Monitoring Agency Report

    15 May 2026, 5:21PM submission of Monitoring Agency Report for Quarter ended March 31, 2026
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    15 May 2026, 5:17PM Monitoring Agency Report for the quarter ended March 31, 2026
  • Amanta Healthcare - Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31,

    11 May 2026, 4:38PM Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider an
  • Amanta Healthcare - Updates

    22 Apr 2026, 5:03PM Amanta Healthcare Limited has informed the Exchange regarding 'clarification on earlier disclosure submitted on April 18th, 2026, pursuant to SEBI (PI
  • Amanta Healthcare - Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulati

    22 Apr 2026, 5:07PM Clarification Letter on earlier disclosure submitted on April 18th, 2026, pursuant to SEBI (PIT) Regulations, 2015
  • Amanta Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    20 Apr 2026, 4:30PM As of March 2026, 63.72% is owned by Promoters and 36.28% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 26.81% and Fore
  • Amanta Healthcare - Updates

    18 Apr 2026, 4:11PM Amanta Healthcare Limited has informed the Exchange regarding 'clarification on earlier disclosure submitted on April 1st, 2026, pursuant to SEBI (PIT
  • Amanta Healthcare - Clarification On Earlier Disclosure Submitted On April 1St, 2026

    18 Apr 2026, 4:06PM Clarification letter on earlier disclosure submitted on April 1st, 2026, pursuant to SEBI (PIT) Regulations, 2015
  • Amanta Healthcare - Resignation

    16 Apr 2026, 2:36PM Amanta Healthcare Limited has informed the Exchange regarding Resignation of Mr V Shrimali as Other of the company w.e.f. April 16, 2026.
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    16 Apr 2026, 2:27PM Intimation of Resignation of Shri Vimal Shrimali, AVP - HR & ADMIN, a Senior Management Personnel
  • Amanta Healthcare - Disclosure under SEBI Takeover Regulations

    10 Apr 2026, 12:38PM Amanta Healthcare Limitedÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Sub
  • Amanta Healthcare - Updates

    9 Apr 2026, 5:27PM Amanta Healthcare Limited has informed the Exchange regarding 'Reconciliation of Share Capital Audit Report'.
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Apr 2026, 10:14AM Amanta Healthcare Limited has informed the Exchange about outcome of site visit
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Outcome

    9 Apr 2026, 10:10AM Analysts/Institutional Investor Meet/Outcome
  • Amanta Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2026, 10:16AM Amanta Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Amanta Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2026, 10:22AM Amanta Healthcare Limited has informed the exchange about certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Amanta Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Apr 2026, 5:49PM Amanta Healthcare Limited has informed the Exchange about Schedule of meet
  • Amanta Healthcare - Updates

    2 Apr 2026, 2:29PM Amanta Healthcare Limited has informed the Exchange regarding 'Disclosures under Regulation 31(4) of SEBI (Substantial Acquisition of Shares andTakeov
  • Amanta Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Apr 2026, 5:46PM We would like to inform you on the schedule of Analysts/Institutional Investors Meeting under SEBI (Listing Obligations and Disclosure Requirements) R
  • Amanta Healthcare - Updates

    1 Apr 2026, 2:45PM Amanta Healthcare Limited has informed the Exchange regarding 'Open Market purchase of Equity Shares by Promoter'.
  • Amanta Healthcare - Open Market Purchase Of Equity Shares By Promoter

    1 Apr 2026, 2:38PM We would like to inform you that we have received Disclosure in Form C, pursuant to Regulation 7(2) of SEBI (PIT) Regulations, 2015 from the Promoter
  • Amanta Healthcare - Trading Window

    28 Mar 2026, 3:06PM Amanta Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Amanta Healthcare - Updates

    26 Mar 2026, 2:23PM Amanta Healthcare Limited has informed the Exchange regarding 'Open Market Purchase of Equity Shares by Immediate Relative of Director'.
  • Amanta Healthcare - Open Market Purchase Of Equity Shares By Immediate Relative Of Director

    26 Mar 2026, 2:19PM We would like to inform you that we have received disclosure in Form C, pursuant to Regulation 7(2) of SEBI (PIT) Regulations, 2015 from Immediate Rel
  • Amanta Healthcare - Open Market Purchase Of Equity Shares By Promoter

    27 Feb 2026, 5:06PM We would like to inform you that we have received disclosure in Form C, pursuant to Regulation 7(2) of the SEBI (PIT) REGULATION, 2015 from the Promot
  • Amanta Healthcare - Updates

    27 Feb 2026, 5:00PM Amanta Healthcare Limited has informed the Exchange regarding 'Amanta Healthcare Limited has informed the Exchange regarding 'Open Market Purchase of

Key fundamentals

Evaluate the intrinsic value of Amanta Healthcare Ltd stock 

Name March-26 March-25 March-24
Assets 454.629 291.3844 271.5179
Liabilities 454.629 291.3844 271.5179
Equity 38.8294 28.8294 26.8294
Gross Profit 59.8585 59.6685 57.49
Net Profit 14.8752 10.5007 3.6332
Cash From Operating Activities 48.4464 46.62 58.073
NPM(%) 5.17 3.82 1.29
Revenue 287.6767 274.7082 280.3403
Expenses 227.8182 215.0397 222.8503
ROE(%) 6.9 4.87 1.68

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Amanta Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 73.65 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 268.38 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 1683.61 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 253.09 -363.15 0.00

Company Info

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Our Company was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership firm "Marck Parenterals (India)" under Part IX of the Companies Act, 1956 and received the Certificate for Commencement of Business on January 06, 1995. The name of our Company was changed to "Marck Biosciences Limited" pursuant to a special resolution passed by our shareholders on October 29, 2005, and a fresh certificate of incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005. Subsequently, the name of our Company was changed to "Amanta Healthcare Limited" pursuant to a special resolution passed by our shareholders on June 12, 2014, and a fresh certificate of incorporation dated June 24, 2014 issued by the Registrar of Companies, Gujarat, at Ahmedabad.Major Events and Milestones:1994- Converted in a Public Limited Company1997- Started implementation of Large Volume Parenterals (LVP) project for Formulations, Fluid Therapy & Irrigation Solution1998- Commencement of L-1 in Block A2002- Launched a specialised production line "LVP Line II" for the manufacture of Large Volume Parenterals in Kheda, Gujarat2005- Launched a specialised production line "SVP Line I" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.2007- Added L-III Large Volume Parenterals Facility for 500 ml products in Block -A2008- Launched a specialised production line "SVP line II" for the manufacture of Small Volume Parenterals in Kheda, Gujarat.- Approval from The National Pharmaceutical Control Bureau - Malaysia (a PIC member)2021- Launched a specialised production line "SteriPort -Debottlenecking"2023- Received WHO- GMP certification for Manufacturing facility at Kheda, Gujarat2024- Got CE Mark Certification for Eye Wash Solutions- Manufacturing out of seven (7) active production lines including SVP and LVP- Granted permission to manufacture and market the product named Linezolid I.V. injection (Domestic)

Parent Organisation

Amanta Healthcare Ltd.

Founded

21/12/1994

Managing Director

Mr.Bhavesh Patel

NSE Symbol

AMANTAEQ

FAQ

OPEN FREE* DEMAT ACCOUNT